Method For Predicting Responsiveness Of Breast Cancer To Antiestrogen Therapy


The invention is directed to diagnostic and monitoring methods (assays) for cancer and kits that may be used in such methods. More particularly, an aspect of the invention relates to the use of activated Stat5 for diagnosing and monitoring breast cancer and predicting the effectiveness of cancer treatment. The invention also relates to the use of screening assays for discovering compounds that effect levels of activated Stat5.

Download PDF
Document Preview
Document History
  • Publication: Jan 5, 2010
  • Application: Oct 30, 2007
    US US 92892407 A
  • Priority: Oct 30, 2007
    US US 92892407 A
  • Priority: Mar 3, 2003
    US US 37628603 A
  • Priority: Jan 17, 2001
    US US 76089901 A

Download Citation

Sign in to the Lens